- Home
- RSKD vs DNTH Comparison
RSKD vs DNTH Comparison
Compare RSKD & DNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RSKD
- DNTH
- Stock Information
- Founded
- RSKD 2012
- DNTH 2015
- Country
- RSKD United States
- DNTH United States
- Employees
- RSKD N/A
- DNTH N/A
- Industry
- RSKD EDP Services
- DNTH Biotechnology: Pharmaceutical Preparations
- Sector
- RSKD Technology
- DNTH Health Care
- Exchange
- RSKD Nasdaq
- DNTH Nasdaq
- Market Cap
- RSKD 579.2M
- DNTH 657.0M
- IPO Year
- RSKD 2021
- DNTH N/A
- Fundamental
- Price
- RSKD $5.01
- DNTH $17.53
- Analyst Decision
- RSKD Hold
- DNTH Strong Buy
- Analyst Count
- RSKD 8
- DNTH 8
- Target Price
- RSKD $6.03
- DNTH $53.00
- AVG Volume (30 Days)
- RSKD 477.6K
- DNTH 255.5K
- Earning Date
- RSKD 05-14-2025
- DNTH 05-12-2025
- Dividend Yield
- RSKD N/A
- DNTH N/A
- EPS Growth
- RSKD N/A
- DNTH N/A
- EPS
- RSKD N/A
- DNTH N/A
- Revenue
- RSKD $333,495,000.00
- DNTH $6,524,000.00
- Revenue This Year
- RSKD $5.90
- DNTH N/A
- Revenue Next Year
- RSKD $9.51
- DNTH N/A
- P/E Ratio
- RSKD N/A
- DNTH N/A
- Revenue Growth
- RSKD 9.30
- DNTH 102.36
- 52 Week Low
- RSKD $3.94
- DNTH $13.37
- 52 Week High
- RSKD $6.65
- DNTH $32.27
- Technical
- Relative Strength Index (RSI)
- RSKD 56.69
- DNTH 37.87
- Support Level
- RSKD $4.84
- DNTH $16.91
- Resistance Level
- RSKD $5.13
- DNTH $18.45
- Average True Range (ATR)
- RSKD 0.22
- DNTH 1.12
- MACD
- RSKD -0.00
- DNTH -0.20
- Stochastic Oscillator
- RSKD 50.00
- DNTH 19.57
About RSKD Riskified Ltd.
Riskified Ltd has built a next-generation eCommerce risk management platform that allows online merchants to create trusted relationships with their consumers. It generates revenue by granting merchants access to its eCommerce risk management platform and reviewing and approving eCommerce transactions for legitimacy. Its merchants include some of the ecommerce brands including Wayfair, Lastminute.com, SHEIN, and Macy's. Its merchants operate in a variety of verticals, including Payments, Money Transfer & Crypto, Tickets & Travel, Electronics, Home, Fashion & Luxury Goods, General Retail and Food. The company derived maximum revenue from Israel.
About DNTH Dianthus Therapeutics Inc.
Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.